Epithelial-mesenchymal (EMT) and mesenchymal-epithelial (MET) transitions occur in the development of human tumorigenesis and are part of the natural history of the process to adapt to the changing microenvironment. In this setting, the miR-200 family is recognized as a master regulator of the epithelial phenotype by targeting ZEB1 and ZEB2, two important transcriptional repressors of the cell adherence (E-cadherin) and polarity (CRB3 and LGL2) genes. Recently, the putative DNA methylation associated inactivation of various miR-200 members has been described in cancer. Herein, we show that the miR200ba429 and miR-200c141 transcripts undergo a dynamic epigenetic regulation linked to EMT or MET phenotypes in tumor progression. The 5 0 -CpG islands of both miR-200 loci were found unmethylated and coupled to the expression of the corresponding miRNAs in human cancer cell lines with epithelial features, such as low levels of ZEB1/ZEB2 and high expression of E-cadherin, CRB3 and LGL2, while CpG island hypermethylation-associated silencing was observed in transformed cells with mesenchymal characteristics. The recovery of miR-200ba429 and miR-200c141 expression by stable transfection in the hypermethylated cells restored the epithelial markers and inhibited migration in cell culture and tumoral growth and metastasis formation in nude mice. We also discovered, using both cell culture and animal models, that the miR-200 epigenetic silencing is not an static and fixed process but it can be shifted to hypermethylated or unmethylated 5 0 -CpG island status corresponding to the EMT and MET phenotypes, respectively. In fact, careful laser microdissection in human primary colorectal tumorigenesis unveiled that in normal colon mucosa crypts (epithelia) and stroma (mesenchyma) already are unmethylated and methylated at these loci, respectively; and that the colorectal tumors undergo selective miR-200 hypermethylation of their epithelial component. These findings indicate that the epigenetic silencing plasticity of the miR-200 family contributes to the evolving and adapting phenotypes of human tumors.
Epithelial-mesenchymal (EMT) and mesenchymal-epithelial (MET) transitions occur in the development of human tumorigenesis and are part of the natural history of the process to adapt to the changing microenvironment. In this setting, the miR-200 family is recognized as a master regulator of the epithelial phenotype by targeting ZEB1 and ZEB2, two important transcriptional repressors of the cell adherence (E-cadherin) and polarity (CRB3 and LGL2) genes. Recently, the putative DNA methylation associated inactivation of various miR-200 members has been described in cancer. Herein, we show that the miR200ba429 and miR-200c141 transcripts undergo a dynamic epigenetic regulation linked to EMT or MET phenotypes in tumor progression. The 5 0 -CpG islands of both miR-200 loci were found unmethylated and coupled to the expression of the corresponding miRNAs in human cancer cell lines with epithelial features, such as low levels of ZEB1/ZEB2 and high expression of E-cadherin, CRB3 and LGL2, while CpG island hypermethylation-associated silencing was observed in transformed cells with mesenchymal characteristics. The recovery of miR-200ba429 and miR-200c141 expression by stable transfection in the hypermethylated cells restored the epithelial markers and inhibited migration in cell culture and tumoral growth and metastasis formation in nude mice. We also discovered, using both cell culture and animal models, that the miR-200 epigenetic silencing is not an static and fixed process but it can be shifted to hypermethylated or unmethylated 5 0 -CpG island status corresponding to the EMT and MET phenotypes, respectively. In fact, careful laser microdissection in human primary colorectal tumorigenesis unveiled that in normal colon mucosa crypts (epithelia) and stroma (mesenchyma) already are unmethylated and methylated at these loci, respectively; and that the colorectal tumors undergo selective miR-200 hypermethylation of their epithelial component. These findings indicate that the epigenetic silencing plasticity of the Introduction About 85% of human tumors are derived from epithelial cells (Edwards et al., 2010) . The epithelialmesenchymal transition (EMT) involves molecular reprogramming of the cells that gradually lose their epithelial features while acquiring mesenchymal attributes that promote cellular detachment from the primary tumor, invasion of adjacent stroma, entry into the systemic circulation and extravasation (Thiery, 2002; Yang and Weinberg, 2008; Acloque et al., 2009; Kalluri and Weinberg, 2009; Polyak and Weinberg, 2009; Thiery et al., 2009; Zeisberg and Neilson, 2009) . This might be a reversible process and the cancer cells could eventually undergo mesenchymal-epithelial transition (MET) phenotype, then proliferate and form distant secondary tumors (Brabletz et al., 2001; Chaffer et al., 2006; Chaffer et al., 2007; Hugo et al., 2007; Polyak and Weinberg, 2009; Thiery et al., 2009; Aokage et al., 2010) . Thus, epithelial and mesenchymal transitions are considered to be hallmarks of tumor progression and also have a central role in metastasis development, the leading cause of cancer-associated mortality.
From a molecular standpoint, most signaling pathways that regulate EMT converge on the control of E-cadherin, a cell adhesion protein crucial for maintaining epithelial structure (Peinado et al., 2007) . Thus, the accurate regulation of transcriptional repressors of this gene, such as ZEB1 (TCF8/ZFHX1A), ZEB2 (SIP1/ZFHX1B), Snail (SNAI1), Slug (SNAI2) and other factors is crucial for normal epithelium and its dysregulation in cancer is associated with EMT (Peinado et al., 2007) . In addition, lack of epithelial organization involves disruption of cell polarity (Etienne-Manneville, 2008; Moreno-Bueno et al., 2008; Bryant and Mostov, 2008; Huang and Muthuswamy, 2010) . The E-cadherin repressor ZEB1 also represses the transcription of some polarity genes, including CRB3 (Crumbs3), MPP5 (Pals1), INADL (Patj) and LLGL2 (Lgl2) (Aigner et al., 2007; Spaderna et al., 2008) .
If ZEB1 and ZEB2 have a central role in EMT, their activity must be finely regulated. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression by targeting messenger RNA (mRNA) transcripts (Medina and Slack, 2008; Agami, 2010) . It is at this level that a miRNA family, miR-200, has important EMT regulatory activity in which it directly targets and inhibits ZEB1 and ZEB2 (Hurteau et al., 2006; Christoffersen et al., 2007; Hurteau et al., 2007; Burk et al., 2008; Gregory et al., 2008; Korpal et al., 2008; Park et al., 2008) . Although several mechanisms may help control miR-200 activity, such as the existence of a double-negative feedback loop between the miR-200 family and ZEB factors based on the presence of Eboxes in miR-200 genes (Bracken et al., 2008; Burk et al., 2008) , we focused on a common disruption in cancer cells: the epigenetic inactivation by CpG island hypermethylation surrounding the transcription start sites (Jones and Baylin, 2007; Esteller, 2008) . Promoter hypermethylation and associated silencing of classical tumor suppressor genes is a molecular hallmark of human tumors (Jones and Baylin, 2007; Esteller, 2008) , and this epigenetic lesion has recently been extended to the DNA methylation-associated silencing of miRNAs with growth-inhibitory features (Saito et al., 2006; Lujambio et al., 2007; Lujambio et al., 2008; Toyota et al., 2008; Huang et al., 2009) . In this regard, recent reports have suggested the presence of hypermethylation-associated silencing of some miR-200 family members (Ceppi et al., 2010; Neves et al., 2010; Vrba et al., 2010; Wiklund et al., 2010) .
The reversibility of epigenetic mechanisms might be a strategy for modulating sequences with distinct expression patterns during tumor progression. This might occur with miR-200 in association with acquiring initial mesenchymal attributes (EMT) and, once the cancer cells have reached a secondary site, regaining some epithelial properties (MET) for colonization and establishment of a secondary tumor. Herein, we show that the 5 0 -CpG island hypermethylation-associated silencing of the miR-200b/200a/429 and miR-200c/141 polycistronic transcripts is a dynamic process that mediates the shifts between EMT and MET phenotypes and contributes to cancer progression and metastasis formation in human tumorigenesis. (Bracken et al., 2008; Neves et al., 2010) and are located within canonical CpG islands (Figure 1a) . The CpG islands of both clusters were densely methylated in RKO, H157 and MDAMB231, whereas HCT116, H441, EBC1 and MCF7 were found to be unmethylated (Figure 1b) . Methylation-specific PCR analyses confirmed the bisulfite genomic sequencing data (Supplementary Figure 1) .
Results

CpG island hypermethylation
To evaluate the impact of CpG methylation in transcription, we analyzed the expression of miR-200 family members. We observed that all the hypermethylated cancer cell lines had significant loss of both mature ( Figure 1c Epigenetic silencing of the miR-200 family is associated with upregulation of ZEB1/ZEB2 and downregulation of their cell-adhesion and polarity-target genes We next wondered about the impact of miR-200 epigenetic silencing on the expression of ZEB1 and ZEB2 and on the downstream cell-adhesion and polarity-target genes, such as E-cadherin (CDH1), CRB3 and LGL2. We observed that miR-200 family CpG island hypermethylated cancer cell lines had higher levels of expression of ZEB1 and ZEB2, quantified by qRT-PCR, than did unmethylated cells, in which these transcripts were inhibited (Supplementary Figure 2) . To reinforce the results of the analysis of the consequences of miR-200 methylation for the entire pathway, we found that miR-200 hypermethylation and ZEB1/ZEB2 upregulation were associated with downregulation in CDH1, CRB3 and LGL2 (Supplementary Figure 2) . The high level of expression of ZEB1 and the converse minimal levels of E-cadherin in miR-200-hypermethylated cancer cell lines, a characteristic feature in the EMT phenotype, were confirmed by western blot (Supplementary Figure 2) .
We also reconstituted miR-200 activity by cloning each cluster (200ba429 and 200c141) followed by its stable transfection in the CpG island-hypermethylated cancer cell lines H157 and MDA-MB-231 (Supplementary Figure 2) . We observed that stable transfection of the 200ba429 or 200c141 pri-miRNA clusters in both miR-200-hypermethylated cell lines caused the downregulation of their target genes, ZEB1 and ZEB2 ( Supplementary  Figure 2) , and an increase in the expression of the downstream cell-adherence and polarity genes, E-cadherin, CRB3 and LGL2 (Supplementary Figure 2) . 
Dynamic epigenetic regulation of miR-200
V Davalos et al pri-miRNAs caused a significant reduction in the migration rate (Fisher's exact test Po0.01) (Figure 2a ). The inhibition of cell migration was not observed before 24 h, and the reduced migration rate observed later was not associated with diminished cell proliferation determined by the MTT assay (Supplementary Figure 3) . Next, we performed in vivo functional experiments in nude mice. First, to test the tumorigenic capability we Dynamic epigenetic silencing of the miRNA-200 family during in vitro-induced EMT and MET Once we had established how the CpG island hypermethylation-associated silencing of miR-200 enhanced the tumorigenic features and re-expression of these transcripts inhibited the malignant phenotype, we began to study the dynamics of the process. In view of the increasing evidences of the importance of EMT and MET in the progression of the primary and metastatic disease (Brabletz et al., 2001; Thiery, 2002; Chaffer et al., 2006 Chaffer et al., , 2007 Hugo et al., 2007; Yang and Weinberg, 2008; Acloque et al., 2009; Thiery et al., 2009; Kalluri and Weinberg, 2009; Polyak and Weinberg, 2009; Zeisberg and Neilson, 2009; Aokage et al., 2010) and the critical roles of the miR-200 family in these processes (Hurteau et al., 2006; Christoffersen et al., 2007; Hurteau et al., 2007; Burk et al., 2008; Gregory et al., 2008; Korpal et al., 2008; Park et al., 2008) , it is plausible that the establishment of the DNA methylation patterns in the 5 0 -CpG islands of the miR-200 might be a reversible process that allows cellular plasticity and adaptation to new microenvironments.
To explore this possibility, we first used a well-known model of induced EMT, the treatment with transforming growth factor b (TGFb) of Madin-Darby canine kidney cells (MDCK) (Moreno-Bueno et al., 2009) . TGFb is a potent inductor of EMT through several pathways, including the Smad pathway (Zavadil and Bottinger, 2005; Pardali and Moustakas, 2007; Xu et al., 2009) . This is a reversible process and the cells can eventually undergo MET upon withdrawal of TGFb from the culture medium (Figure 3a (Figure 3c ). Most notably, when these cells then underwent a change to a MET phenotype after TGFb withdrawal from the medium (Figure 3a) , the previously methylated CpG islands recovered the original unmethylated CpG status (Figure 3b) , and the expression of the miR-200 was restored (Figure 3c) . We also performed quantitative chromatin immunoprecipitation studies for three histone modification marks in the miR-200ba429 and miR200c141 CpG islands in the EMT/MET MDCK model: two marks of active transcription (H3K4 trimethylation and H3K36 trimethylation) and one of silencing (H3K27 trimethylation). We observed that the DNA unmethylated CpG islands of the miR-200 loci were enriched in active marks (H3K4 trimethylation and H3K36 trimethylation) and depleted of the transcriptional silencing H3K27 trimethylation mark (Supplementary Figure 4 ). In contrast, the gain of CpG island methylation of the miR-200ba429 and miR-200c141 loci was associated with an increase in the silencing mark (H3K27 trimethylation) and a depletion of the active marks (H3K4 trimethylation and H3K36 trimethylation) (Supplementary Figure 4) . MDCK cells that underwent EMT upon TGFb use at the time points of 10, 20 and 30 days were also treated with 5 0 -aza-2 0 -deoxycytidine during 72 h. We observed that upon the use of DNA-demethylating agent, the miR-200ba429 and miR-200c141 CpG islands underwent hypomethylation events associated with a restoration of the expression of the corresponding miRNA transcripts (Figure 3d and Supplementary Figure 5) . The epigenetic reactivation of the described miR-200 loci was associated with the acquisition of epithelial features, such as the downregulation of ZEB1 and the upregulation of E-cadherin (Supplementary Figure 5) .
The role of dynamic miR-200 epigenetic silencing in the establishment of EMT and MET was confirmed in two additional experimental lines. First, the described miR-200 hypermethylation-associated inactivation in the TGFb-induced EMT was accompanied by increased ZEB1 expression, loss of E-cadherin and the acquisition of a spindle-like shape, a mesenchymal phenotype marked by Vimentin (Supplementary Figure 6) . Second, the subsequent acquisition of a MET phenotype upon TGFb depletion was not only characterized by the hypomethylation and re-expression of the aforementioned miR-200ba429 and miR-200c141 clusters, but also by a depletion of ZEB1 and Vimentin expression and the enhancement of the E-cadherin signal (Supplementary Figure 6 ). The ZEB1 and E-cadherin promoter CpG islands were found unmethylated in all the different stages of EMT and MET studied in MDCK cells (Supplementary Figure 7) .
Dynamic epigenetic silencing of the miRNA-200 family during in vivo metastasis formation The observation of the reversible miR-200 CpG island methylation patterns in cell culture during EMT and MET transitions, described above, prompted us to consider whether these dynamic epigenetic changes also took place in in vivo models of metastases where cancer To address this matter, we used two mouse models: a paired human primary/metastasis breast cancer cell line obtained from the animal system and the analyses of liver metastases generated in nude mice by the intrasplenic injection of a human colorectal cancer cell line.
In the first case, we used an available model to analyze the EMT process occurring in metastasis, the paired breast cancer cell lines 468PT and 468LN (Vantyghem et al., 2005) . The 468PT cell line was generated by stable transfection of the human breast adenocarcinoma cell line MDA-MB-468 with the pEGFP-C2 expression vector, whereas 468LN was derived from lung metastases dissected from a nude mouse following orthotopic injection with 468PT cells (Vantyghem et al., 2005) . In contrast to the epithelioid phenotype of the parental 468PT cell line, 468LN are spindle-shaped cells, morphological changes associated with EMT. The 468LN cells produce extensive spontaneous lymph node metastases following orthotopic injection in nude mice, in contrast to the poorly metastatic MDA-MB-468 (Vantyghem et al., 2005) . In agreement with the data Figure 9) . In the second approach, we generated a mouse model of hepatic metastasis by intrasplenic injection of the human colorectal cancer cell line SW620. We injected 2 Â 10 6 cells into 15 animals and verified the occurrence of metastasis in liver 8 weeks later. SW620 was able to generate macroscopic liver metastasis after 2 months in 9 of the 15 (60%) mice (Figure 4d ). The miR-200ba429 5 0 -CpG island remained unmethylated in all cases (Supplementary Figure 10) . Strikingly, in two of the mice carrying the hepatic metastases, the miR-200c141 epigenetic pattern was distinct from that observed in the parental cell line: if the original SW620 had an unmethylated CpG island (Figure 4e and Supplementary Figure 11 ) associated with expression of the transcript (Figure 4f ), the liver metastases of SW620 had experienced dense miR-200c141 CpG island methylation (Figure 4e and Supplementary Figure 11 ) and loss of expression (Figure 4f ) in association with the gain of EMT features such as ZEB1, ZEB2 and Vimentin overexpression and E-cadherin depletion (Figure 4g ). These latter results in colorectal dissemination, together with the paired 468PT/468LN breast cancer experiment described above, highlight the role of epigenetic plasticity in miR-200 activities and later tumor propagation.
Differential miR-200 CpG island methylation in epithelial and stromal cells of human colonic mucosa
Having demonstrated that miR-200 CpG island methylation-associated silencing was characteristic of the mesenchymal phenotypes, while the unmethylated and expressing status of the CpG island was linked to epithelial features, we investigated whether these different DNA methylation patterns were also observed in human primary tissues. We took normal colon mucosa as a model. Bisulfite genomic sequencing of multiple clones (Figure 5a ) and methylation-specific PCR analyses (Supplementary Figure 11) of the miR-200ba429 and miR-200c141 5 0 -CpG islands in primary total normal colorectal mucosa samples revealed a mixture of hypermethylated and unmethylated alleles in all the studied cases (n ¼ 10). These results may reflect the existence of a heterogeneous population within the sample: methylated/silenced and unmethylated/expressing. The stromal and epithelial components of the normal colon mucosa were good candidates in each respective category. Thus, we mechanically isolated the Lieberku¨hn colorectal crypts (the epithelial component) (Figure 5b The next question to address was how the specific identified miR-200 CpG island methylation pattern that distinguishes the epithelia from the mesenchymal component of the normal colon mucosa could be disrupted in human colorectal tumorigenesis. Thus, we used laser microbeam microdissection and pressure catapulting to analyze the four tissue components found in 25 colorectal cancer patients: normal epithelium (the crypts) and stroma neighboring the colorectal tumor and, within the malignant pathological mass, its tumor 0 -CpG islands of the stroma of normal colorectal mucosa continued to be densely methylated in the stroma within colorectal tumors (Figure 6b ) with minimal miRNA expression (Figure 6c) . However, the 5 0 -CpG island of miR200c141 underwent a hypermethylation event in the tumor epithelial cells relative to the unmethylated status of epithelium from the normal mucosa in 40% (10/25) of colorectal cancer patients (Figure 6b ). miR-200c141 CpG island hypermethylation in the TE was associated with the transcriptional silencing of the transcript (Figure 6c) . Following immunostaining for the epithelial marker E-cadherin in the 25 studied TE samples, among the cases that showed minimal expression of E-cadherin, miR-200c-141 CpG island hypermethylation was observed in six of eight (75%) cases (Supplementary Figure  12) . None of the 25 analyzed TE samples showed E-cadherin CpG island hypermethylation (Supplementary Figure 12 ). miR-200c-141 CpG island hypermethylation was not observed in pre-neoplastic colorectal lesions (five microdissected adenomas) (Supplementary Figure 13) . It is worth noting that the miR-200ba429 CpG island did not undergo dense methylation in the TE in the studied samples (Supplementary Figure 14) , which suggests that different tissue and cancer-type activities might exist within the miR-200 family.
Discussion
The dynamic nature of the contribution of the DNA methylation mark to the 'survival skills' of cancer cells within the human body host is emerging as a critical tool for accomplishing this goal. Although many external and microenvironmental agents could be involved in shifting DNA methylation patterns, it is interesting that TGFb seems to have a role in one case, that of the MDCK system. TGFb induced EMT, and its withdrawal caused MET, linked with the corresponding (Yang et al., 2009) . Likewise, acquisition of CpG methylation in several gene promoters, such as Twist, has been described upon serum-induced EMT in immortalized human mammary epithelial-expressing oncogenic ras cells (Dumont et al., 2008) . Thus, local microenvironment and signals from tumor-associated stroma, including TGFb that appear to be important for the induction and functional activation of EMT-related pathways (Zavadil and Bottinger, 2005; Pardali and Moustakas, 2007; Xu et al., 2009) , might also mediate these effects through the action of epigenetic switches such as miR-200 5 0 -CpG island methylation events. The finding of possible triggers and controllers of the observed miR-200 loci DNA methylation dynamics in EMT would be extremely interesting. TGFb has been involved in the establishment of DNA methylation patterns in cancer cells (reviewed by Chou et al., 2010) and in the activity of two epigenetic proteins, MTA1 (Pakala et al., 2011) and HDAC6 (Shan et al., 2008) , in EMT. In addition, other histone modifiers, such as LSD1 (Lin et al., 2010) , CREB-binding protein (Abell et al., 2011) and SIRT1 (Eades et al., 2011) , also contribute to EMT.
Our study provides further clues about the paradoxical role of the miR-200 family during tumor progression and metastasis. During early tumor development, from the 5 0 -unmethylated miR-200 CpG islands the transcripts are produced and initially 'secure' the epithelial phenotype. However, the tumors progress and gain CpG promoter hypermethylation with a lack of miR-200 expression that promotes metastasis. In this regard, lower levels of miR-200c have been associated with a higher frequency of lymph node metastases in non-small cell lung cancer patients (Ceppi et al., 2010) , and miR-200 downregulation is observed in metastatic lymph nodes (Baffa et al., 2009) . However, once the micrometastases have been established, CpG island demethylation and gain of miR-200 expression could act as a macrometastasis promoter at the secondary (Dykxhoorn et al., 2009) or with more epithelial phenotypes (Chaffer et al., 2006) more efficiently produced local colonization growth and macrometastases than those with low miR-200 levels or mesenchymal-like phenotypes. Thus, if metastatic tumors tend to recapitulate the traits of the primary tumor from which they arose, including epithelial features favorable to tumor growth in the secondary organ, CpG hypermethylation of the miR-200 family could be a transitional state. Under such circumstances, epigenetic silencing of these master regulators of the epithelial phenotype could initially facilitate the dissemination of cancer cells, although restoring unmethylated miR-200 CpG island status and undergoing MET could be advantageous once the cells have reached the secondary site.
Many aspects remain to be investigated in future research. The first is the recognition of the presence of different miR-200 5 0 -CpG island DNA methylation patterns according to the epithelial or mesenchymal origin of the cell type. This finding is supported by the distinct miR-200c141 methylation profile observed in mammary epithelial cells and isogenic fibroblasts (Vrba et al., 2010) . In addition, a miR-200 downregulation has been reported in the mesenchymal component of endometrial carcinosarcomas in comparison with the epithelial part, confirming the role of miR-200 in EMT in human tumors (Castilla et al., 2011) . These results indicate the need for careful microdissection experiments if we want to exploit the potential of miR-200 CpG island hypermethylation as a biomarker of tumor behavior for future clinical purposes. Second, our results might provide a molecular base for new uses of pharmacological compounds with DNA-demethylating activity in the treatment of cancer patients (Mack, 2006; Issa, 2007; Esteller, 2008; Kaiser, 2010) . Druginduced miR-200 CpG island demethylation, which restores the expression of these transcripts, might inhibit tumor progression and micrometastasis formation mediated by EMT, as suggested by our in vitro and in vivo results. This area warrants further pre-clinical research, because of the potential benefits it offers for the treatment of cancer patients with metastatic disease, where extremely few therapeutic options are currently available.
Materials and methods
Cell lines and DNA methylation analysis Cell lines and culture conditions are detailed in Supplementary Methods. For epigenetic drug treatments, cells were treated with 2 mM 5-aza-2 0 -deoxycytidine (Sigma, St Louis, MO, USA) for 72 h. For TGFb treatments, recombinant human TGFb (R&D systems, Minneapolis, MN, USA) was added to the culture medium at a final concentration of 5 ng/ml. CpG islands were identified in silico using Methyl Primer Express v1.0 software (Applied Biosystems, Carlsbad, CA, USA). DNA methylation status was established by bisulfite genomic sequencing of multiple clones and methylation-specific PCR. Primers are listed in Supplementary Table 1. RNA extraction and real-time qRT-PCR Total RNA was extracted using Trizol (Invitrogen, San Diego, CA, USA) and DNase-treated with Turbo DNA-free (Ambion, Austin, TX, USA). mRNA expression was analyzed using SYBR Green (Applied Biosystems). For miRNA quantification, TaqMan Pri-miRNA or MicroRNA Assays (Applied Biosystems) (Chen et al., 2005) were used according to the manufacture's protocol. Further information is described in Supplementary Methods. Primers and TaqMan assays are listed in Supplementary Table 1 .
Protein extraction, western blot and immunofluorescence Cell pellets were lysed in RIPA buffer containing complete protease inhibitor cocktail (Roche, Mannheim, Germany). Proteins were quantified with DC Protein Assay (Bio-Rad, Hercules, CA, USA) and 50 mg of whole-cell lysates were separated by SDS-PAGE. Blots were probed using anti-ZEB1 antibody (sc-10572, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Vimentin (CBL-202, Chemicon-Millipore, Billerica, MA, USA) or anti-E-cadherin (ab-1416, Abcam, Cambridge, UK). Proteins were detected using horseradish peroxidase-conjugated secondary antibodies. For immunofluorescence, cells were cultured directly on coverslips and double immunostainings were performed as detailed in Supplementary Methods.
miR-200 cloning and stable transfection
The genomic regions surrounding the pri-miRNA sequences of miR-200 family members were amplified using primers listed in Supplementary Table 1 . Products were directionally cloned in pSilencer 4.1-CMV puro (Ambion). Cells seeded in six-well plates were transfected using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions.
Wound-healing assay
Control and miR-200 stably transfected cells were grown to confluence, and a wound was made through the monolayer using a p1000 tip. Accurate measures of the wounds were taken during the time course to calculate the migration rate according to the equation: percentage wound healing ¼ ((wound length at 0 h)À(wound length at 24, 48 or 72 h))/ (wound length at 0 h) Â 100. Two independent experiments were performed.
Mouse xenograft and metastasis models
Five-week-old male athymic nu/nu mice (Charles River, Wilmington, MA, USA), housed under specific pathogen-free conditions, were used in this study. For xenografts, a total of 3.5 Â 10 6 cells were subcutaneously injected in each flank of the mouse. The right flank was used for RKO control cells (empty vector) and the left for the miR-200c141 stably transfected RKO cells. Tumor development was monitored every 5 days and the tumor width (W) and length (L) were measured. Tumor volume was estimated according to the formula V ¼ p/ 6 Â L Â W 2 . Mice were killed 45 days after injection, and tumors were then excised and weighed. For the experimental metastasis assay, mice were anesthetized, the spleens were exposed through a cut on the left flank and 2 Â 10 6 control (empty vector) or miR-200c141 stably transfected RKO cells were injected into the middle of spleen. In order to minimize local tumor growth, the spleens were resected 48 h after injection. Hepatic metastasis were examined 8 weeks later, Colonic crypt isolation from fresh tissue Colonic tissues were obtained from surgical resection of colorectal cancer patients at the Bellvitge Hospital, Barcelona, Spain. Written informed consents were obtained from all patients. Colonic crypts were isolated by a previously described method (Fujimoto et al., 2002) . Lamina propria and crypt samples were snap-frozen in liquid nitrogen and stored at À80 1C before DNA and RNA extraction.
Laser microdissection from paraffin-embedded and frozen tissues Tissues were provided by the Department of Pathology, Hospital Sa˜o Joa˜o, Porto, Portugal. All patients gave written consent and the hospital Ethics Committee approved the study. Laser microbeam microdissection and pressure catapulting process is detailed in Supplementary Methods. A minimum of 1,500 cell equivalents were isolated. DNA and RNA were extracted using a RecoverAll Total Nucleic Acid Isolation Kit for FFPE Tissues (Ambion).
Statistical analyses
Experiments were performed in triplicate and Fisher's exact test or Student's two-tailed t-test were used to identify statistical significance of differences between group means.
